Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Goldman Sachs and Houlihan Lokey top M&A financial advisers in North America during H1 2026, reveals GlobalData

Goldman Sachs and Houlihan Lokey were the top mergers and acquisitions (M&A) financial advisers in North America during the first half (H1) of 2026 by value and volume, respectively, according to the latest financial advisers league table GlobalData, a leading intelligence and productivity platform. An analysis of GlobalData’s Financial Deals Database reveals that Goldman Sachs […]
Read more

Continuous glucose monitoring market in Europe to grow at 4% CAGR through 2036, forecasts GlobalData

Europe’s continuous glucose monitoring (CGM) market is expected to witness steady growth, driven by the increasing prevalence of diabetes, rising adoption of connected diabetes management technologies, and growing demand for real-time glucose monitoring. The integration of CGM with automated insulin delivery (AID) systems is transforming diabetes care by enabling more personalized and data-driven treatment while […]
Read more

2025 marked a standout year for women’s sport, reveals GlobalData

2025 saw several significant landmarks, with international competitions, including the UEFA Women’s European Championship and Women’s Rugby World Cup, providing major global platforms that elevated visibility, accelerated professional investment, and helped set new benchmarks for attendance, broadcast reach, and commercial growth across women’s sport. The 2025 Women’s Rugby World Cup, which was held in England, […]
Read more

Smart packaging key to complex regulatory and consumer informational systems, says GlobalData

FMCG product packaging is at the core of a growing informational system, encompassing regulators, packaging producers, their clients, and consumers. Through the ongoing evolution and roll-out of new forms of smart packaging, its overall impact is increasing beyond the boundaries of a simple product container, says GlobalData, a leading intelligence and productivity platform. With regulatory […]
Read more

AI infrastructure buildout drives massive market cap divergence in APAC during Q2 2026, reveals GlobalData

Asia-Pacific’s (APAC) second quarter (Q2) 2026 market capital table tells one dominant story: the AI infrastructure buildout has become the region’s single biggest wealth-creation and wealth-destruction engine, splitting winners and losers along lines that have little to do with traditional sector logic, according to GlobalData, a leading intelligence and productivity platform. The memory supercycle SK […]
Read more

Commercial insurers face volatility as impending UK leadership shift triggers SME uncertainty, reveals GlobalData

Andy Burnham’s impending takeover from Sir Keir Starmer as UK Prime Minister introduces a wave of political ambiguity that could destabilize commercial insurers. Little is known about any changes Burnham will make that could impact insurance at this point. However, uncertainty is always a concern for SMEs in the UK, which could trouble commercial insurers […]
Read more

MSCopilot Detect emerges as early contender for scalable remote MS monitoring, says GlobalData

Digital biomarkers are gaining momentum in multiple sclerosis (MS) care, with new findings highlighting the potential of smartphone-based assessments to transform disability monitoring. Early evidence supporting MSCopilot Detect use underscores growing industry efforts to enable scalable, remote, and standardized disease assessment, a shift that could reshape clinical  patient monitoring, and the evaluation of MS disease […]
Read more

Real-world data point to patient experience as next battleground for anti-CD20 therapies in RMS, says GlobalData

As real-world evidence (RWE) increasingly shapes competition in the relapsing multiple sclerosis (RMS) market, TG Therapeutics is leaning on patient-reported outcomes to carve out space for Briumvi (ublituximab) in a crowded anti-CD20 monoclonal antibody (mAb) field. There is growing importance on patient-centered outcomes as manufacturers seek competitive advantage beyond comparable clinical efficacy in MS treatment, […]
Read more

AI coding hiring gains momentum as industries scale real-world use cases, reveals GlobalData

AI coding is revolutionizing software engineering by integrating AI and agentic workflows throughout the development lifecycle. Organizations across industries are increasingly hiring professionals to implement AI coding tools for tasks like code reviews, automated testing, documentation generation, and governance. This shift accelerates software delivery while ensuring consistency, security, and compliance, ultimately leading to higher-quality outputs […]
Read more

India venture capital activity drops amid investor caution and smaller deal sizes, reveals GlobalData

India’s venture capital (VC) market experienced a slowdown from January to May 2026, with deal volume and funding value dropping roughly 9% and 6% year-on-year (YoY), respectively. This decline reflects a more cautious investment landscape characterized by a reduced frequency of big-ticket financing rounds and a shift toward smaller deal sizes, according to GlobalData, a […]
Read more

Cyber insurance gap leaves SMEs dangerously exposed to cyberattacks, finds GlobalData

Cyberattacks are becoming an increasingly significant threat to small and medium enterprises (SMEs), yet insurance adoption remains disproportionately low. Limited awareness of cyber risks, affordability challenges, and evolving threat landscapes continue to leave many SMEs financially exposed. As cyber incidents grow in severity and sophistication, closing the protection gap has become a pressing priority for […]
Read more

China’s first dual BAFF/APRIL therapy approval signals new phase of competition in IgA nephropathy market, says GlobalData

China’s approval of the first dual BAFF/APRIL-targeting therapy for IgA nephropathy marks a significant shift in a treatment landscape long constrained by limited disease-modifying options and reliance on corticosteroids. The milestone highlights the growing role of innovative biologics in addressing persistent unmet needs, while underscoring the increasing influence of Chinese biopharma innovation in a competitive […]
Read more

China defies global slump with YoY surge in VC volume and 220% funding growth in January-May 2026, reveals GlobalData

China’s venture capital (VC) market surged during January to May 2026, defying a 3% decline in global deal volume with strong year-on-year (YoY) gains. Breaking away from the global contraction, the Asian country experienced a robust 41% YoY increase in the total number of announced deals. This momentum was further underscored by an even stronger […]
Read more

Takeda’s oveporexton among key value-driving biopharma catalysts in Q3 2026, reveals GlobalData

Regulatory catalysts are set to shape biopharma sentiment in Q3 2026, with a selective pipeline of approval decisions and clinical milestones highlighting where innovation is most likely to create value. Foremost among them is Takeda Pharmaceutical’s oveporexton, whose anticipated FDA decision could validate a disease-modifying approach in narcolepsy type 1 (NT1), while pivotal readouts across […]
Read more

SpaceX accelerates AI push with strategic hires and advanced engineering roles, reveals GlobalData

Space Exploration Technologies Corp (SpaceX), which recently went public with its valuation surpassing $2 trillion, is accelerating its expansion of applied artificial intelligence (AI) capabilities across engineering and platform operations. Continued hiring for specialized AI roles highlights a focused effort to deploy and manage advanced AI models. Collectively, these moves underscore SpaceX’s commitment to operationalizing […]
Read more

Mobile data segment to drive New Zealand mobile service revenue growth during 2025-2030, forecasts GlobalData

New Zealand’s mobile service revenue is poised to grow at a compound annual growth rate (CAGR) of 3.3% from $1.9 billion in 2025 to $2.2 billion in 2030, mainly supported by growth in mobile data service segment, reveals GlobalData, a leading intelligence and productivity platform. GlobalData’s New Zealand Mobile Broadband Forecast (Q1 2026) indicates that […]
Read more

South Korea bone grafts and substitutes market to grow at 4% CAGR through 2033, forecasts GlobalData

Driven by the rising incidence of orthopedic disorders, increasing volume of spinal fusion procedures, and growing demand for advanced bone regeneration technologies, South Korea’s bone grafts and substitutes market is expected to witness steady expansion at a CAGR of 4% through 2033. This is further supported by the continued innovation in biologic bone graft materials […]
Read more
1 2 3 4 5 … 206